These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1689429)

  • 41. Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects.
    Tomita K; Araie M; Tamaki Y; Nagahara M; Sugiyama T
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1144-51. PubMed ID: 10235547
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regional hemodynamic effects of clonidine in congestive heart failure.
    Magorien RD; Hermiller JB; Unverferth DV; Leier CV
    J Cardiovasc Pharmacol; 1985; 7(1):91-6. PubMed ID: 2580157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiischemic and hemodynamic effects of intravenous isradipine, a new calcium antagonist, in coronary heart disease: a comparative double-blind cross-over study with nifedipine.
    Burger W; Herholz H; Burger K; Kober G
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):764-8. PubMed ID: 1703598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium channel blockers in congestive heart failure: theoretic considerations and clinical experience.
    Colucci WS; Fifer MA; Lorell BH; Wynne J
    Am J Med; 1985 Feb; 78(2B):9-17. PubMed ID: 3976695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure.
    Ryman KS; Kubo SH; Lystash J; Stone G; Cody RJ
    Am J Cardiol; 1986 Sep; 58(7):583-8. PubMed ID: 3751928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory blood pressure monitoring in elderly hypertensives treated with the new calcium antagonist, nilvadipine.
    Tsuchihashi T; Tsukashima A; Matsumura K; Abe I; Tominaga M; Nakao Y; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1991; 41(3):255-7. PubMed ID: 1748143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
    Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
    Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic effects of nifedipine in congestive heart failure.
    Matsumoto S; Ito T; Sada T; Takahashi M; Su KM; Ueda A; Okabe F; Sato M; Sekine I; Ito Y
    Am J Cardiol; 1980 Sep; 46(3):476-80. PubMed ID: 7415993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.
    Greenbaum RA; Wan S; Evans TR
    Eur J Clin Pharmacol; 1986; 30(4):383-6. PubMed ID: 3743613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effects of nilvadipine on retinal microcirculation and systemic circulation].
    Ogata Y; Kaneko T; Kayama N; Ueno S
    Nippon Ganka Gakkai Zasshi; 2000 Oct; 104(10):699-705. PubMed ID: 11081304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.
    Levenson J; Simon AC; Bouthier J; Maarek BC; Safar ME
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):107S-113S. PubMed ID: 4027144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure.
    Lefkowitz CA; Moe GW; Armstrong PW
    Am J Cardiol; 1987 Jan; 59(3):59B-63B. PubMed ID: 3101477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between the pharmacokinetic and pharmacodynamic profile of nilvadipine in the dog.
    Wu WH; Henderson BM; Lanc R; Garnes D; Yacobi A; Silber BM
    Drug Metab Dispos; 1988; 16(2):222-7. PubMed ID: 2898337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.
    Levine TB; Olivari MT; Garberg V; Sharkey SW; Cohn JN
    Circulation; 1984 Mar; 69(3):548-53. PubMed ID: 6319045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the dose-concentration-dependent hemodynamic effects of nifedipine in heart failure.
    Green JA; Nara AR; Gengo FM
    J Clin Pharmacol; 1987 Aug; 27(8):574-81. PubMed ID: 3655007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.